ORIGINAL RESEARCH article
Front. Nutr.
Sec. Nutritional Epidemiology
Volume 12 - 2025 | doi: 10.3389/fnut.2025.1652372
Renal Hyperfiltration With and Without Metabolic Syndrome: Differential Implications for Cardiovascular Events, Kidney Failure, and Mortality
Provisionally accepted- 1Division of Nephrology, Department of Internal Medicine, Kyung Hee University Medical Center, Kyung Hee University, Seoul, Republic of Korea
- 2Statistics Support Part, Medical Science Research Institute, Kyung Hee University, Seoul, Republic of Korea
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background Renal hyperfiltration (RHF) and metabolic syndrome (MetS) share common pathophysiology and are both associated with adverse clinical outcomes. However, their combined impact remains unclear. Methods In total, 278,552 propensity score-matched individuals were enrolled in the Korean National Health Insurance Service database (2009–2011). Participants were divided into four groups based on RHF and MetS status, and cardiovascular (CV) events, end-stage kidney disease (ESKD) progression, and all-cause mortality were evaluated. Results Compared to non-MetS with normal renal filtration (NRF), MetS with NRF was associated with a significant increase in the risk of CV events, which was further amplified when combined with RHF (adjusted HR = 1.44, 95% CI = 1.35 – 1.55, P for interaction = 0.047). Patients with RHF exhibited more pronounced increases in the HRs for CV events than those with NRF as the number of dysfunctional metabolic components increased (P for interaction = 0.019). The risk of ESKD progression was not increased in non-MetS with RHF; however, it was significantly higher in patients with MetS alone and highest in those with both MetS and RHF (adjusted HR = 3.23, 95% CI = 1.61 – 6.47). The risk of all-cause mortality was elevated in patients with RHF or MetS alone and highest in those with both RHF and MetS (adjusted HR = 1.41, 95% CI = 1.31 – 1.52). Conclusions The clinical significance of RHF differs based on MetS status, with their coexistence posing the highest risk for CV events, ESKD progression, and all-cause mortality. A synergistic interaction between RHF and MetS was evident in the risk of CV events.
Keywords: renal hyperfiltration, metabolic syndrome, Cardiovascular event, end-stage kidney disease, All-cause mortality
Received: 23 Jun 2025; Accepted: 26 Sep 2025.
Copyright: © 2025 Lee, Kim, Kim, Jeong, Jeong and Hwang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Hyeon Seok Hwang, hwanghsne@gmail.com
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.